Global P2X7 Receptor Antagonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 P2X7 Receptor Antagonists Market Overview

• 1.1 Product Overview and Scope of P2X7 Receptor Antagonists
• 1.2 Classification of P2X7 Receptor Antagonists by Types
  • 1.2.1 Global P2X7 Receptor Antagonists Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global P2X7 Receptor Antagonists Revenue Market Share by Types in 2018
  • 1.2.3 GSK1482160
  • 1.2.4 AZD9056
  • 1.2.5 EVT 401
  • 1.2.6 JNJ 55308942 & JNJ 54175446
  • 1.2.7 AKP-23494954/RQ-00466479
  • 1.2.8 Others
• 1.3 Global P2X7 Receptor Antagonists Market by Application
  • 1.3.1 Global P2X7 Receptor Antagonists Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Inflammatory Diseases
  • 1.3.3 Central Nervous System Diseases
  • 1.3.4 Immune System Disorders
• 1.4 Global P2X7 Receptor Antagonists Market by Regions
  • 1.4.1 Global P2X7 Receptor Antagonists Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) P2X7 Receptor Antagonists Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) P2X7 Receptor Antagonists Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) P2X7 Receptor Antagonists Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) P2X7 Receptor Antagonists Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) P2X7 Receptor Antagonists Status and Prospect (2014-2024)
• 1.5 Global Market Size of P2X7 Receptor Antagonists (2014-2024)

2 Manufacturers Profiles

• 2.1 GlaxoSmithKline
  • 2.1.1 Business Overview
  • 2.1.2 P2X7 Receptor Antagonists Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 AstraZeneca
  • 2.2.1 Business Overview
  • 2.2.2 P2X7 Receptor Antagonists Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 AstraZeneca P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Janssen
  • 2.3.1 Business Overview
  • 2.3.2 P2X7 Receptor Antagonists Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Janssen P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 RaQualia Pharma
  • 2.4.1 Business Overview
  • 2.4.2 P2X7 Receptor Antagonists Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 RaQualia Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Evotec
  • 2.5.1 Business Overview
  • 2.5.2 P2X7 Receptor Antagonists Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Evotec P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Asahi Kasei Pharma
  • 2.6.1 Business Overview
  • 2.6.2 P2X7 Receptor Antagonists Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Pfizer
  • 2.7.1 Business Overview
  • 2.7.2 P2X7 Receptor Antagonists Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Pfizer P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2017-2018)

3 Global P2X7 Receptor Antagonists Market Competition, by Players

• 3.1 Global P2X7 Receptor Antagonists Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 P2X7 Receptor Antagonists Players Market Share
  • 3.2.2 Top 10 P2X7 Receptor Antagonists Players Market Share
• 3.3 Market Competition Trend

4 Global P2X7 Receptor Antagonists Market Size by Regions

• 4.1 Global P2X7 Receptor Antagonists Revenue and Market Share by Regions
• 4.2 North America P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 4.3 Europe P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 4.5 South America P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)

5 North America P2X7 Receptor Antagonists Revenue by Countries

• 5.1 North America P2X7 Receptor Antagonists Revenue by Countries (2014-2019)
• 5.2 USA P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 5.3 Canada P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 5.4 Mexico P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)

6 Europe P2X7 Receptor Antagonists Revenue by Countries

• 6.1 Europe P2X7 Receptor Antagonists Revenue by Countries (2014-2019)
• 6.2 Germany P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 6.3 UK P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 6.4 France P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 6.5 Russia P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 6.6 Italy P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)

7 Asia-Pacific P2X7 Receptor Antagonists Revenue by Countries

• 7.1 Asia-Pacific P2X7 Receptor Antagonists Revenue by Countries (2014-2019)
• 7.2 China P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 7.3 Japan P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 7.4 Korea P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 7.5 India P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)

8 South America P2X7 Receptor Antagonists Revenue by Countries

• 8.1 South America P2X7 Receptor Antagonists Revenue by Countries (2014-2019)
• 8.2 Brazil P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 8.3 Argentina P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 8.4 Colombia P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue P2X7 Receptor Antagonists by Countries

• 9.1 Middle East and Africa P2X7 Receptor Antagonists Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 9.3 UAE P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 9.4 Egypt P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)
• 9.6 South Africa P2X7 Receptor Antagonists Revenue and Growth Rate (2014-2019)

10 Global P2X7 Receptor Antagonists Market Segment by Type

• 10.1 Global P2X7 Receptor Antagonists Revenue and Market Share by Type (2014-2019)
• 10.2 Global P2X7 Receptor Antagonists Market Forecast by Type (2019-2024)
• 10.3 GSK1482160 Revenue Growth Rate (2014-2024)
• 10.4 AZD9056 Revenue Growth Rate (2014-2024)
• 10.5 EVT 401 Revenue Growth Rate (2014-2024)
• 10.6 JNJ 55308942 & JNJ 54175446 Revenue Growth Rate (2014-2024)
• 10.7 AKP-23494954/RQ-00466479 Revenue Growth Rate (2014-2024)
• 10.8 Others Revenue Growth Rate (2014-2024)

11 Global P2X7 Receptor Antagonists Market Segment by Application

• 11.1 Global P2X7 Receptor Antagonists Revenue Market Share by Application (2014-2019)
• 11.2 P2X7 Receptor Antagonists Market Forecast by Application (2019-2024)
• 11.3 Inflammatory Diseases Revenue Growth (2014-2019)
• 11.4 Central Nervous System Diseases Revenue Growth (2014-2019)
• 11.5 Immune System Disorders Revenue Growth (2014-2019)

12 Global P2X7 Receptor Antagonists Market Size Forecast (2019-2024)

• 12.1 Global P2X7 Receptor Antagonists Market Size Forecast (2019-2024)
• 12.2 Global P2X7 Receptor Antagonists Market Forecast by Regions (2019-2024)
• 12.3 North America P2X7 Receptor Antagonists Revenue Market Forecast (2019-2024)
• 12.4 Europe P2X7 Receptor Antagonists Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific P2X7 Receptor Antagonists Revenue Market Forecast (2019-2024)
• 12.6 South America P2X7 Receptor Antagonists Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa P2X7 Receptor Antagonists Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology